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The Recognition of Active Retrolental Fibroplasia 
R. Michael Nisbet, MD* 
As the incidence of retrolental fibroplasia increases, physi-
cians must become familiar with its appearance. This 
report describes the examination techniques and morphol-
ogy of the active and regressive stages of retrolental fibro-
plasia. 
After retrolental fibroplasia (RLF) was described by Terry 
in 1942 (1), it rapidly became the single largest cause of 
infant blindness in the United States. A national coopera-
tive study (2) designed to seek causes demonstrated that the 
length of time the premature infant is kept in an oxygen-
enriched environment is an important factor in causing 
RLF As a result, the use of oxygen for premature infants was 
severely curtailed for several years. 
In the ensuing years, however, pediatricians tended to use 
oxygen more liberally to manage idiopathic respiratory 
distress syndrome, and the incidence of RLF increased (3). 
Consequently, ophthalmologists are now often called upon 
to screen premature infants. 
Infant Screening 
The infant at greatest risk of developing RLF is one with a 
birth weight of less than 1500 gms (3.3 Ib) who suffers from 
the respiratory distress syndrome with multiple episodes of 
apnea (3). All infants with a birth weight of less than 2000 
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gms (4.2 Ib) or a gestational age under 34 weeks should be 
screened if they received oxygen in concentrations greater 
than room air. 
Because ophthalmoscopic monitoring of vasospasm is in-
accurate and early examination is impeded by vitreous 
haze and embryologic vascular remnants (Fig. 1), the best 
time to perform the examination is just before the infant is 
discharged from the nursery. 
Examination Techniques 
The ocular fundus cannot be examined properly unless the 
pupil is dilated. Tropicamide {V2%) and phenylephrine 
(2.5%) are instilled in the conjunctival cul-de-sac 30 min-
utes and again 15 minutes before the examination takes 
place. Tropicamide relaxes the iris sphincter and phe-
nylephrine stimulates the dilator muscle to produce maxi-
mal dilatation. Systemic absorption of tropicamide may 
produce lethargy or apnea. Phenylephrine may make the 
eyelid skin blanch, but it causes no adverse effects. 
The binocular indirect ophthalmoscope is indispensable 
for viewing the retinal periphery. A wider view is obtained 
ifa 2X condensing lens with a diameter less than 2.5 cm is 
used. Examination with this instrument may be combined 
with scleral depression to evaluate the retina as far anterior 
as the ora serrata. 
The child may be examined within the Isolette if its body 
temperature is difficult to maintain (Fig. 2). Otherwise, the 
examination should be performed outside for better visual-
ization. The infant wil l be more docile if examined soon 
after feeding. Its eyelids may be held apart with the fingers 
or a Sauer infant eyelid speculum (Fig. 3). If the speculum 
is used, the child's cornea must be kept moist with artificial 
tears. 
If active disease is found, photographic documentation is 
helpful. Fluorescein angiography is a valuable research 
tool but is not used routinely. Both fundus photography and 
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Fig. 1 
Persistent Tunica Vasculosa Lentis. 
Fig. 2 
Examination through clear dome of Isolette. 
Fig. 3 
Eyelids retracted with infant speculum. 
fluorescein angiography are made easier by the pediatric 
photography platform designed to be used with the Zeiss 
fundus camera (4) (Fig. 4). 
Recognition of Active Disease 
The earliest definite clinical sign of RLF is tortuosity and 
dilatation o f the vessels near the disc (Fig. 5), caused by 
increased blood flow to the abnormal vascular channels in 
the peripheral retina. The arteriovenous shunt, which de-
velops at the junction of vascularized and avascular retina, 
is the most prominent structure in the fundus of the eye 
affected by RLF and is an important landmark to identify 
(Fig. 6). Neovascularization occurs near this structure, and 
normal vascularization begins here during the regressive 
stages. In full-term infants, the temporal periphery of the 
retina is normally not vascularized until after birth, so it is 
not surprising that in premature infants a wide avascular 
zone is present temporally. However, avascularity alone 
does not imply the presence of active RLF. 
The major criterion for the diagnosis is a prominent demar-
cation line betwen vascular and avascular retina, with 
evidence of abnormal vascularization at that junction. Pre-
retinal proliferative neovascularization develops imme-
diately posterior to the arteriovenous shunt and is usually 
associated with areas of capillary nonprofusion (Fig. 7). It 
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Fig. 4 
Pediatric photography platform attached to Zeiss fundus camera. 
Fig. 5 
Posterior pole of eye wi th active retrolental fibroplasia. 
Fig. 6 
Prominent arteriovenous shunt in temporal periphery wi th inserting retinal vessels. 
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Fig. 7 
Preretinal proliferative neovascularization (top); fluorescein angiogra-
phy shows avascular retina, neovascularization, and capillary nonperfu-
sion (bottom). 
Fig. 8 
Enlarged neovascular frond with hemorrhage along arteriovenous shunt. 
looks like other peripheral proliferative retinopathies, espe-
cially those associated with the sickling hemoglobin-
opathies. 
As the active phase develops into a more advanced stage, 
the neovascular fronds enlarge, hemorrhage appears near 
the fronds, in the vitreous and along the arteriovenous 
shunt, and the avascular retina may be thickened and 
elevated (Fig. 8). 
It is important to recognize the early signs of regression of 
the active disease. O'Grady (5) first suggested that the 
beginning of the regression process may be signaled by a 
double demarcation line composed of the original ar-
teriovenous shunt and a fine brush border of normal retinal 
vasculature. As vascularization becomes normal, the shunt 
is left behind and atrophies. Remnants may remain as a 
sentinel of the disease process (Fig. 9). 
The role of the ophthalmologist is to advise physicians and 
parents of premature infants. Knowledge of the natural 
history of the disease process and recognition of its stages 
are paramount to accomplishing that goal. 
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Fig. 9 
A. Temporal periphery at age 10 weeks shows double demarcation line; B. Fluorescein angiogram shows fine brush border of normal 
retinal vessels; C . At 13 weeks, vessel growth has continued and shunt atrophy begins; D. At 16 weeks, only a gray remnant of the 
arteriovenous shunt remains. 
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